Repro USMLE step 1 9-1 (1) Flashcards
This male patient presents with infertility, moderate hypertension, low levels of testosterone, and high levels of luteinizing hormone. This man likely has?
Klinefelter syndrome, a genetic disorder that occurs in 1/850 male subjects. Men with Klinefelter have testicular atrophy, feminine body shapes (often, but not always, presenting with gynecomastia), long extremities, and sparse body hair. This diagnosis is a common cause of hypogonadism found in an infertility work-up.
This patient’s serum level of LH is high secondary to his underlying testicular atrophy. Resultant abnormal Leydig cell function leads to the decrease in serum testosterone, thus altering the normal feedback loop with the anterior pituitary that normally releases LH to stimulate testosterone synthesis in Leydig cells.
The genotype in Klinefelter syndrome is XXY As there are two X chromosomes in these men, a Barr body (inactivated X chromosome) can be seen on?
karyotyping and occasionally on microscopic examination at the cellular level.
Note that in rare situations, 46,XX men also can have Klinefelter syndrome; in this setting, the development of testes presumably is due to translocation of a small portion of chromosomal material containing the testis-determining factor to an X chromosome.
An abdominal CT scan may reveal abnormalities in Turner syndrome (streak ovaries) or androgen insensitivity syndrome, and it could reveal atrophied testes in Klinefelter syndrome. However, karyotyping is more accurate for determining this syndrome.
Ciliary movement may be useful in diagnosing Kartegener syndrome, but the syndrome does not cause abnormal testosterone and LH levels, which are seen in this patient. Defective migration of GnRH cells and anosmia are classic symptoms of Kallman syndrome, which this man does not appear to have.
Sperm counts are commonly done in suspected male infertility, but the blood test findings point towards a diagnosis of?
Klinefelter, which is best diagnosed with karyotyping.
The smell test is used to diagnosis anosmia, which is a characteristic of Kallmann syndrome. Testosterone levels are low in these patients, but levels of gonadotropin-releasing hormones are also low (vs this patient’s high LH level).
Klinefelter syndrome, which is caused by ?
the genotype XXY, results in a phenotypically male individual with testicular atrophy, gynecomastia, sparse body hair, and infertility. Karyotyping is performed to diagnose Klinefelter syndrome.
The patient’s vaginal pruritis, white discharge, vaginal pH of 4.2, and recent history of broad-spectrum antibiotic use make a clinical vaginal infection with Candida albicans the most likely diagnosis. The use of antibiotics likely eliminated the majority of the normal vaginal flora, such as?
lactobacilli (gram-positive facultative anaerobes). A 10% potassium hydroxide preparation can reveal the characteristic budding yeast of C. albicans and pseudohyphae.
Lactobacilli make up a majority of the normal flora of the vagina. The composition of the normal flora varies during the premenarchal, childbearing, and menopausal stages; but a key feature of the normal vaginal environment is a low pH (3.5–4.2), which inhibits growth of other, possibly pathogenic, organisms. This pH is likely maintained by the lactobacilli, and when numbers of these bacteria are reduced during the course of antibiotic treatment (eg, with tetracycline), the vaginal pH may relatively?
increase (4.0–4.5), making conditions favorable for the yeast C. albicans to grow. This patient has the symptoms of a yeast infection, and diagnosis is made by staining vaginal discharge with a 10% potassium hydroxide preparation on which pseudohyphae are seen.
The presence of protozoa, such as Trichomonas vaginalis, would not be consistent with the lack of trophozoites on a wet mount. This patient’s symptoms are consistent with the overgrowth of, rather than the loss of, a dimorphic budding yeast (ie, C. albicans). Gram-positive cocci are not responsible for?
maintaining the protective low pH of the vagina, and obligate anaerobes are not present in the normal vaginal flora.
Lactobacilli predominate in the normal vaginal flora and help protect against foreign organisms by maintaining a low pH of 3.5–4.2. Loss of lactobacilli as a result of antibiotic use can lead to overgrowth of?
C. albicans. C. albicans causes vulvovaginitis, which presents with vaginal pruritis and a white discharge.
Because the fetus in this case lacks mesonephric, or Wolffian, ducts, any structures that develop from the mesonephric ducts would be absent. The prostate is the only genital structure listed that does not develop from the mesonephric ducts. The prostate develops?
from the urogenital sinus in response to dihydrotestosterone (DHT). The urogenital sinus also forms the prostatic urethra.
Most internal male genital structures develop in the mesonephric (Wolffian) ducts in response to testosterone. This can be remembered with the mnemonic BEEDS: trigone of the Bladder, Epididymis, Ejaculatory duct, Ductus deferens, Seminal vesicles. The external male genitalia (penis and scrotum), as well as the prostate, develop under the influence of DHT.
In normal development the SRY gene is present on the Y chromosome and will produce testes-determining factor, leading to the development of the testes. Next during development, Sertoli cells will secrete anti-Müllerian factor. Anti-Müllerian factor inhibits the development of the paramesonephric ducts and prevents the female phenotype from forming, thus promoting the development of the mesonephric (Wolffian) duct structures. In this case, the developing fetus was found to have no mesonephric ducts, indicating that no male internal genitalia would form. The urachus develops from ?
the allantois, an embryologic derivative of the yolk sac. All other answers listed are part of male internal genitalia, including ejaculatory duct, epididymis, bladder, seminal vesicles, and vas deferens. As stated previously, these structures develop in the mesonephric (Wolffian) ducts.
The prostate develops from?
the urogenital sinus. The mesonephric ducts develop into the male internal genital structures, which can be remembered with the mnemonic BEEDS: Bladder trigone, Epididymis, Ejaculatory duct, Ductus deferens, Seminal vesicles.
This woman is in the secretory (also called luteal) phase of her menstrual cycle, which occurs after ovulation (approximately day 14 of a typical menstrual cycle) through the end of the cycle.
Progesterone increases after?
ovulation (as it is produced by the corpus luteum) and usually peaks around day 21–22. Progesterone is responsible for the increased endometrial production of glycogen and the differentiation and maintenance of the endometrium. The estrogen level is high just prior to ovulation (it induces the LH peak), but falls dramatically around the time of ovulation (when the follicle becomes the corpus luteum). After ovulation, the estrogen levels begin to rise again, returning to a relative peak during the luteal phase (around day 21). The high levels of estrogen and progesterone act in negative feedback during the luteal phase, inhibiting the release of FSH and LH; therefore during the secretory phase, progesterone and estrogen levels are high and FSH and LH levels are low due to negative feedback.
Choice A represents a combination of hormone changes seen during the end of the menstrual cycle, when the corpus luteum degenerates. This woman is on day 19 of her cycle and, thus, still has a corpus luteum. Answer B is characteristic of the follicular phase of the menstrual cycle, during which estrogen increases slowly due to the maturation of the follicle(s) under the influence of FSH. This woman is in the secretory, or luteal, phase of her cycle, not follicular. Answer C predominates in the days prior to ovulation. Progesterone levels remain?
low and stable, due to the lack of a corpus luteum, which is responsible for the secretion of the hormone later in the cycle. Choice D is seen immediately following ovulation, when estrogen levels are decreasing (prior to increasing again during the luteal phase) and progesterone levels are increasing
During the first half of the luteal phase (approximately days 14–21 of the menstrual cycle), estrogen and progesterone levels increase and exert a negative feedback on the secretion of FSH and LH, leading to?
low FSH and LH levels.
Androgenic steroids are used to treat hypogonadism either due to failure of the hypothalamic-pituitary-gonadal axis (secondary hypogonadism) or due to Leydig cell dysfunction (primary hypogonadism). Patients should be warned that androgens cause?
premature closing of the epiphyseal plates by promoting calcium deposition in the bones.